-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
NUNZIA PHARMACEUTICAL Co quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2022.
- NUNZIA PHARMACEUTICAL Co Operating Income (Loss) for the quarter ending September 30, 2022 was -$227K, a 559% decline year-over-year.
- NUNZIA PHARMACEUTICAL Co annual Operating Income (Loss) for 2021 was -$78.1M.
- NUNZIA PHARMACEUTICAL Co annual Operating Income (Loss) for 2020 was -$39.3K, a 16.9% decline from 2019.
- NUNZIA PHARMACEUTICAL Co annual Operating Income (Loss) for 2019 was -$33.6K, a 23.8% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)